Open AccessCOVID-19 related acute respiratory distress syndrome: Pathological, radiological and clinical concordance
Author(s) -
Fatma Yıldırım,
Pınar Yıldız Gülhan,
Meltem Şimşek
Publication year - 2021
Publication title -
tuberkuloz ve toraks/tüberküloz ve toraks
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.157
H-Index - 18
ISSN - 0494-1373
DOI - 10.5578/tt.20219708
Subject(s) - ards , medicine , concordance , pneumonia , diffuse alveolar damage , radiological weapon , acute respiratory distress , pathological , severe acute respiratory syndrome , respiratory disease , covid-19 , disease , intensive care medicine , coronavirus , respiratory system , lung , infectious disease (medical specialty) , surgery
Severe coronavirus 2019 disease (COVID-19) represents viral pneumonia from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection leading to acute respiratory distress syndrome (ARDS). However, when ARDS occurs as part of COVID-19, it has different features. The strategy of breathing support is very important in treating COVID-19 related ARDS (CARDS). Though it meets the CARDS Berlin definition, COVID-19 pneumonia is a specific disease with different phenotypes. Recently, it has been suggested that CARDS has two phenotypes, type L (Type 1 or non-ARDS) and type H (Type 2, ARDS), and these phenotypes respond differently to respiratory support treatments. In this review, after mentioning the pathophysiology and radiological relationship of CARDS, the definition and treatment approaches of two different forms of CARDS were discussed.